PAK1 and non-small cell lung carcinoma: The Kaplan–Meier survival curves showed that PAK1 overexpression was not associated with recurrence-free survival in 159 patients diagnosed with early-stage (≤IIIA) NSCLC (χ2 = 0.158, p = 0.695; Figure 3B).